C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive - analogs
| Description «C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive» | ||||||
|
||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 43% Compare C95.1 Chronic leukaemia of unspecified cell type
- 42% Compare C91.1 Chronic lymphocytic leukaemia of B-cell type
- 25% Compare C91.0 Acute lymphoblastic leukaemia [ALL]
- 24% Compare C96.2 Malignant mast cell tumour
- 20% Compare C92.5 Acute myelomonocytic leukaemia
- 20% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 20% Compare C94 Other leukaemias of specified cell type
- 20% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 20% Compare C94.2 Acute megakaryoblastic leukaemia
- 20% Compare C95 Leukaemia of unspecified cell type
- 20% Compare C95.0 Acute leukaemia of unspecified cell type
- 15% Compare C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissues
- 15% Compare C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
- 15% Compare C92.7 Other myeloid leukaemia
- 15% Compare C92 Myeloid leukaemia
- 15% Compare C91.9 Lymphoid leukaemia, unspecified
- 15% Compare C93 Monocytic leukaemia
- 15% Compare C91.5 Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
- 15% Compare C92.2 Atypical chronic myeloid leukaemia, BCR/ABL-negative
- 15% Compare C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
- 15% Compare C96.9 Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
- 15% Compare C94.7 Other specified leukaemias
- 15% Compare C95.9 Leukaemia, unspecified
- 15% Compare C91 Lymphoid leukaemia
- 15% Compare C90.1 Plasma cell leukaemia
- 14% Compare B44.7 Disseminated aspergillosis
- 11% Compare C93.1 Chronic myelomonocytic leukaemia
- 10% Compare C11.8 Malignant neoplasm, overlapping lesion of nasopharynx
- 10% Compare C56 Malignant neoplasm of ovary
- 10% Compare C16.9 Malignant neoplasm, stomach, unspecified
- 10% Compare C54.9 Malignant neoplasm, corpus uteri, unspecified
- 10% Compare D06 Carcinoma in situ of cervix uteri
- 10% Compare C55 Malignant neoplasm of uterus, part unspecified
- 10% Compare C17.9 Malignant neoplasm, small intestine, unspecified
- 10% Compare C11.1 Malignant neoplasm, posterior wall of nasopharynx
- 10% Compare C11.9 Malignant neoplasm, nasopharynx, unspecified
- 10% Compare C91.4 Hairy-cell leukaemia
- 10% Compare D05 Carcinoma in situ of breast
- 10% Compare C11.2 Malignant neoplasm, lateral wall of nasopharynx
- 10% Compare C11.0 Malignant neoplasm, superior wall of nasopharynx
- 10% Compare C21.0 Malignant neoplasm, anus, unspecified
- 10% Compare C11.3 Malignant neoplasm, anterior wall of nasopharynx
- 10% Compare C77.0 Secondary and unspecified malignant neoplasm, lymph nodes of head, face and neck
- 10% Compare C57.4 Malignant neoplasm, uterine adnexa, unspecified
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnosis.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.